Bioinformatics Market to Reach USD 29.1 Billion by 2031 | 12.8% CAGR | AI, Cloud & Multi-Omics Drive Genomics & Personalized Medicine

The Global Bioinformatics Market reached USD 11.4 billion in 2022 and is projected to grow to USD 29.1 billion by 2031, exhibiting a CAGR of 12.8% during 2024-2031. The market has expanded rapidly in recent years and is set to continue its upward trajectory as advancements in cloud computing, big data analytics, artificial intelligence (AI), machine learning (ML), and multi-omics integration redefine how biological data is processed, analyzed, and interpreted.

Growth is further fueled by the rising adoption of genomics and personalized medicine, increasing focus on drug discovery and development, and the surging need for efficient biological data management and sequencing analysis. Demand for nucleic acid and protein sequencing continues to accelerate, supported by ongoing research initiatives, substantial government funding, and strong industry participation. North America remains a key contributor to market expansion, driven by robust R&D infrastructure and major players such as Illumina Inc., Thermo Fisher Scientific, Qiagen NV, and others actively innovating within the sector.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioinformatics-market?sai-v

The Bioinformatics Market is the sector that develops and provides computational tools, software, and platforms to analyze biological data, supporting research, drug discovery, and personalized medicine.

Key Developments
✅ November 2025: QIAGEN acquired Parse Biosciences to expand its single-cell sequencing and bioinformatics capabilities, enhancing its portfolio in genomics and precision medicine research.

✅ September 2025: BGI Genomics deployed its AI-powered bioinformatics platform to support large-scale genomic initiatives and population-health programs, highlighting the growing global demand for precision medicine and advanced analytics.

✅ August 2025: Partek integrated its bioinformatics workflow platform with a major clinical-informatics system, enabling end-to-end data analysis workflows and improving usability for research and clinical applications.

✅ July 2025: Major companies, including Roche and Thermo Fisher Scientific, launched or upgraded bioinformatics tools for genomics, proteomics, drug discovery, and NGS data analysis, reflecting strong growth in omics research and AI-driven analytics.

✅ June 2025: Adoption of cloud-based, scalable bioinformatics platforms continued to rise, supporting genomics, precision medicine, and research applications across healthcare, pharmaceuticals, and agriculture.

Mergers, Acquisitions & Strategic Moves
✅ June 2025: Bioinformatics firms expanded global infrastructure and data centers to scale omics data analysis services, particularly in fast-growing regions like Asia-Pacific.

✅ August 2025: Partek's platform integration with a clinical-informatics system strengthened end-to-end bioinformatics and clinical data workflow capabilities.

✅ November 2025: QIAGEN's acquisition of Parse Biosciences reinforced its position in single-cell sequencing and high-growth bioinformatics segments.

Key Players
Illumina Inc. | Thermo Fisher Scientific | Qiagen NV | Agilent Technologies | PerkinElmer | Celera Corporation | Dassault Systèmes | Data4Cure | Geneva Bioinformatics SA | Lineage Cell Therapeutics

Key Highlights
Illumina Inc. - Holds a 16.8% market share, driven by its next-generation sequencing platforms, comprehensive genomic data solutions, and strong adoption in clinical and research genomics.

Thermo Fisher Scientific - Holds a 15.4% market share, supported by its extensive portfolio of bioinformatics tools, high-throughput sequencing systems, and cloud-based analytics platforms for life sciences.

Qiagen NV - Holds a 13.9% market share, fueled by its molecular diagnostics assays, bioinformatics software, and strong presence in translational research and clinical genomics.

Agilent Technologies - Holds a 12.1% market share, strengthened by its analytical instruments, integrated omics solutions, and genomics data analysis platforms for pharmaceutical and biotech research.

PerkinElmer - Holds a 10.7% market share, driven by its bioinformatics software, laboratory automation systems, and growing applications in drug discovery and precision medicine.

Celera Corporation - Holds a 7.8% market share, supported by its genomic databases, bioinformatics pipelines, and strong legacy in human genome mapping and annotation.

Dassault Systèmes - Holds a 6.4% market share, fueled by its 3DEXPERIENCE platform, computational biology solutions, and digital modeling tools for drug design and systems biology.

Data4Cure - Holds a 5.3% market share, driven by its AI-powered bioinformatics solutions, translational research platforms, and growing adoption in oncology and precision medicine.

Geneva Bioinformatics SA - Holds a 4.6% market share, supported by its data analytics services, genomics interpretation platforms, and focus on research collaborations.

Lineage Cell Therapeutics - Holds a 3.0% market share, backed by its integration of bioinformatics with cell therapy development, stem cell research, and personalized medicine applications.

Purchase this report before year-end and unlock an exclusive 30% discount: https://www.datamintelligence.com/buy-now-page?report=bioinformatics-market?sai-v
(Purchase 2 or more Reports and get 50% Discount)

Market Drivers
• Growing demand for personalized medicine and genomics research driving advanced data analysis.

• Increasing adoption of bioinformatics tools for drug discovery, clinical diagnostics, and biomarker identification.

• Expansion of high-throughput sequencing technologies generating large-scale biological data.

• Rising use of AI and machine learning for predictive modeling in healthcare and life sciences.

• Growing need for integration of multi-omics data (genomics, proteomics, metabolomics) for comprehensive analysis.

• Increasing focus on precision medicine and targeted therapies.

• Rising investment in bioinformatics startups and research collaborations across pharmaceutical and biotech industries.

Industry Developments
• Launch of AI-powered bioinformatics platforms for faster genomic data interpretation.

• Expansion of cloud-based bioinformatics solutions for scalable and cost-efficient data analysis.

• Development of integrative bioinformatics tools for multi-omics and systems biology research.

• Growing partnerships between bioinformatics companies and pharmaceutical firms for drug discovery programs.

• Introduction of user-friendly bioinformatics software with visualization and reporting capabilities.

• Increased funding for computational biology and genomics research initiatives.

• Integration of bioinformatics with digital health platforms for personalized patient care.

Regional Insights
North America - 42% share: "Driven by strong genomics research, high investment in biotech and pharma R&D, and widespread adoption of bioinformatics solutions in precision medicine."

Europe - 28% share: "Supported by government-funded genomics initiatives, increasing focus on translational research, and growing adoption of AI in bioinformatics applications."

Asia Pacific - 25% share: "Fueled by rapid growth of biotechnology and pharmaceutical sectors, rising genomics research, and increasing adoption of cloud-based bioinformatics platforms."

Latin America - 3% share: "Boosted by expanding research collaborations, emerging biotech companies, and growing need for bioinformatics in disease diagnostics."

Middle East & Africa - 2% share: "Driven by increasing investment in healthcare research, genomic initiatives, and rising collaborations with global bioinformatics firms."

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bioinformatics-market?sai-v

Key Segments

➥ By Product & Services Type
Knowledge Management Tools: Platforms that aggregate, organize, and provide insights from biomedical and clinical data to support research and decision-making.

Bioinformatics Platforms: Software solutions enabling analysis, interpretation, and visualization of biological and genomic data for research and clinical applications.

Services: Consulting, integration, data analysis, training, and managed services supporting bioinformatics workflows and platform deployment.

➥ By Application
Genomics: Analysis of genetic sequences, variant detection, and genome-wide studies to understand hereditary traits and diseases.

Gene Engineering: Tools and platforms for designing, editing, and validating genetic modifications for research and therapeutic purposes.

Drug Development: Applications supporting target identification, molecular modeling, pharmacogenomics, and preclinical/clinical research.

Omics: Integration and analysis of proteomics, metabolomics, transcriptomics, and other omics data to understand complex biological systems.

Personalized Medicine: Platforms enabling individualized treatment strategies based on patient-specific genetic, molecular, and clinical information.

Others: Includes functional genomics, epigenetics, systems biology, and other emerging applications in life sciences research.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.